These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16197859)

  • 1. [Immunologic reconstitution after allogeneic stem cell transplant].
    Lacerda JF
    Acta Med Port; 2004; 17(6):471-80. PubMed ID: 16197859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution following allogeneic peripheral blood stem cell transplants.
    Shenoy S; Mohanakumar T; Todd G; Westhoff W; Dunnigan K; Adkins DR; Brown RA; DiPersio JF
    Bone Marrow Transplant; 1999 Feb; 23(4):335-46. PubMed ID: 10100577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving outcome of allogeneic stem cell transplantation by immunomodulation of the early post-transplant environment.
    Barrett J
    Curr Opin Immunol; 2006 Oct; 18(5):592-8. PubMed ID: 16872820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired B-cell reconstitution in lymphoma patients undergoing allogeneic HSCT: an effect of pretreatment with rituximab?
    Buser A; Stern M; Arber C; Medinger M; Halter J; Rovo A; Favre G; Lohri A; Tichelli A; Gratwohl A
    Bone Marrow Transplant; 2008 Oct; 42(7):483-7. PubMed ID: 18695668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
    Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
    Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-CD34+ cells, especially CD8+ cytotoxic T cells and CD56+ natural killer cells, rather than CD34 cells, predict early engraftment and better transplantation outcomes in patients with hematologic malignancies after allogeneic peripheral stem cell transplantation.
    Kim DH; Won DI; Lee NY; Sohn SK; Suh JS; Lee KB
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):719-28. PubMed ID: 16785061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
    Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
    Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
    Avigan D; Wu Z; Joyce R; Elias A; Richardson P; McDermott D; Levine J; Kennedy L; Giallombardo N; Hurley D; Gong J; Kufe D
    Bone Marrow Transplant; 2000 Jul; 26(2):169-76. PubMed ID: 10918427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients.
    Fallen PR; McGreavey L; Madrigal JA; Potter M; Ethell M; Prentice HG; Guimarães A; Travers PJ
    Bone Marrow Transplant; 2003 Nov; 32(10):1001-14. PubMed ID: 14595388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors influencing T-cell receptor excision circle (TRECs) counts following allogeneic stem cell transplantation in adults.
    Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Montserrat E
    Transpl Immunol; 2006 Jun; 16(1):52-9. PubMed ID: 16701177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation.
    Larosa F; Marmier C; Robinet E; Ferrand C; Saas P; Deconinck E; Bulabois CE; Rohrlich PS; Ledu K; Helias P; Tiberghien P; Cahn JY
    Bone Marrow Transplant; 2005 May; 35(9):859-68. PubMed ID: 15765116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell regeneration in pediatric allogeneic stem cell transplantation.
    Olkinuora H; Talvensaari K; Kaartinen T; Siitonen S; Saarinen-Pihkala U; Partanen J; Vettenranta K
    Bone Marrow Transplant; 2007 Feb; 39(3):149-56. PubMed ID: 17211435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.
    Kim DH; Sohn SK; Won DI; Lee NY; Suh JS; Lee KB
    Bone Marrow Transplant; 2006 Jun; 37(12):1119-28. PubMed ID: 16699530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients.
    Heining C; Spyridonidis A; Bernhardt E; Schulte-Mönting J; Behringer D; Grüllich C; Jakob A; Bertz H; Finke J
    Bone Marrow Transplant; 2007 May; 39(10):613-22. PubMed ID: 17384658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation.
    Lilleri D; Gerna G; Fornara C; Chiesa A; Comolli G; Zecca M; Locatelli F
    J Infect Dis; 2009 Mar; 199(6):829-36. PubMed ID: 19239337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update.
    Feuchtinger T; Richard C; Pfeiffer M; Neuhäuser F; Lücke J; Handgretinger R; Greil J; Bader P; Klingebiel T; Schlegel PG; Jahn G; Niethammer D; Lang P
    Klin Padiatr; 2005; 217(6):339-44. PubMed ID: 16307420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.